In this Substack’s ongoing anecdotal repurposed drug crowdsourcing series comes another incredible story, this time courtesy of an X post.
Readers of this Substack appreciate that the Nobel Prize winning miracle compound Ivermectin can cure a broad range of neurodegenerative diseases, from the slow kill bioweapon “vaccine” induced prion-based adverse events to dementia and Alzheimer’s; to wit:
DEMENTIA & ALZHEIMER'S CURE: Fungal Infection in the Brain Produces Effects Similar to Alzheimer's
A recent article by The Epoch Times posited that fungal infections may be the cause of neurodegenerative diseases.
And just like the synergistic combination therapy approach represents the most powerful ‘holy grail’ (turbo) cancer cure in plain sight, so too does the addition of Fenbendazole to Ivermectin increase the odds of reversing Alzheimer’s:
A Multifaceted Treatment Approach To ALZHEIMER’S DISEASE
The journey of evidence-based medicine, particularly in the treatment of complex diseases such as cancer and Alzheimer’s, is marked by pivotal shifts in approach and philosophy, many of which can be traced back to the early 20th century.
A previous anecdotal subscriber success story published two years ago by this Substack added some additional color on this developing research:
This anecdotal experience is of particular importance given that we now know that dementia and Alzheimer’s may be caused by fungal and viral infections. We may also extrapolate that these two diseases are exacerbated by VAIDS, especially given the surge of premature dementia and Alzheimer’s cases since the DEATHVAX™ rollout.
A research paper entitled, Fenbendazole Controls In Vitro Growth, Virulence Potential, and Animal Infection in the Cryptococcus Model describes a study that investigated the antifungal potential of fenbendazole against Cryptococcus neoformans and Cryptococcus gattii. The study found that fenbendazole was effective in inhibiting the growth of both species of fungi in vitro and in vivo. The article also found that fenbendazole reduced the virulence of C. neoformans in a mouse model of infection.
The authors of the study conclude that fenbendazole is a promising new antifungal agent for the treatment of cryptococcal infection. Fenbendazole is an inexpensive and well-tolerated drug that has been used safely for many years in the treatment of parasitic infections.
And since it is now strongly suspected that cryptococcal infection causes dementia and Alzheimer’s, the administration of repurposed drugs like fenbendazole represents truly safe and extremely effective treatment strategies.
Another research study entitled In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles investigated the in vitro activity of ten benzimidazole derivatives and amphotericin B against three isolates of Cryptococcus neoformans.
The authors found that four of the benzimidazole derivatives, including mebendazole and albendazole, had moderately high activity against Cryptococcus neoformans. Fenbendazole, however, was 10-fold more active than the other benzimidazole derivatives and 2-fold more active than amphotericin B.
The authors also tested ten additional clinical isolates of Cryptococcus neoformans against fenbendazole, mebendazole, and albendazole. They found that the isolates were similarly susceptible to all three drugs.
The authors concluded that fenbendazole is a promising new antifungal agent for the treatment of cryptococcal infection. Fenbendazole is an inexpensive and well-tolerated drug that has been used safely for many years in the treatment of parasitic infections.
Some additional details from the article:
• The IC50s (drug concentrations inhibiting 50% of growth) of fenbendazole against the three isolates of Cryptococcus neoformans were 0.01 to 0.02 microgram/ml.
• The LC90s (drug concentrations lethal to 90% of the cells) of fenbendazole against the three isolates of Cryptococcus neoformans were 0.1 to 0.2 microgram/ml.
• The fenbendazole MICs (minimum inhibitory concentrations) for the ten additional clinical isolates of Cryptococcus neoformans were 0.01 to 0.04 microgram/ml.
Therefore, we may conclude that fenbendazole is extremely potent even at minuscule dosing amounts.
And as per GaryP’s above comment, incorporating fenbendazole in combination with other supplements and repurposed drugs like ivermectin may very well attenuate Cryptococcus neoformans-induced brain fog, and restore lucidity even in patients suffering from advanced and severe cases of dementia and Alzheimer’s.
Which brings us to an X thread that was directed at yours truly last night:
It most certainly was this Substack, and PCPatriot essentially restored his mother’s cognition in just three days, which is both unsurprising and yet utterly astounding!
If PCPatriot were to add fenbendazole, his mother may benefit even more.
Also, yours truly suggested adding low dose Lithium Orotate to the protocol:
Some additional research on Lithium Orotate and Alzheimer’s:
Low-dose lithium against dementia
Low Dose Lithium May Stop Alzheimer’s Disease in Its Tracks
Nearly a decade ago, The Psychiatric Times published an article entitled, Lithium for Alzheimer Prevention: What Are We Waiting for?, concluding:
Whatever the reason, these data further establish that “the magic ion” in even tiny doses is psychoactive. Perhaps such data will increase willingness to use lithium for patients with bipolar disorder, especially in low doses. And that, after all, is my point: lithium is underutilized in depression and bipolar disorders. If more people knew of this Alzheimer research, hesitation might decrease substantially.
What are we waiting for? We are waiting for BigPharma to continue its iatrogenesis on behalf of their Intelligence-Industrial Complex handlers methodically executing their democide program; but we digress…
Thus, adding low dose lithium to the powerful combination therapy of Fenbendazole and Ivermectin may represent the most powerful one-two-three punch for eradicating this devastating neurological disease once and for all.
So, please take advantage of the BIGGEST SALE EVER, and stock up on both Fenbendazole and Ivermectin at 25% off!
All of the amazing products that this Substack has been promoting for many years now that you have been sourcing from VIREX HEALTH (that website is hacked) will now be offered exclusively by RESOLVX HEALTH.
The RESOLVX HEALTH rebranding will ensure that not only will all of the currently available products like VIR-X, PetMectin, PetDazole, FishCycline, CBD-X and FLAV-X always be available, but many new and exciting health products will also be forthcoming very soon!
To celebrate the RESOLVX HEALTH rebranding and expansion, please take advantage of our BIGGEST SALE EVER by using code RESOLVX25 for 25% off on all products!
This sale has been extended, and now ends on Friday, May 9th (midnight eastern time), 2025.
Please use code RESOLVX25 to receive 25% OFF on not just the Nobel Prize winning miracle compound Ivermectin, but also on the no less miraculous Fenbendazole, Doxycycline, the full spectrum organic CBD oil containing 5,000 milligrams of activated cannabinoids and hemp compounds CBD, CBN & CBG, the powerful immune support nutraceutical and spike support formula VIR-X, and the healthy sugar alternative FLAV-X!
Upon adding products to your cart, please go to the cart icon at the top right corner of your browser page and click it, then choose the VIEW CART option whereby you will be redirected to a page where you can enter the code RESOLVX25 in the Use Coupon Code field.
Please contact the company directly with any product questions: info@resolvx.health
Typo edited.
I have followed you since the get go…..and I just wanted take the time to thank you for all the good that you’ve done…. for all the important posts that you have written… For sharing your knowledge and wisdom… and for the products that you share…It is a blessing to know that there are people like you in our world🦋
Blessings Always Sir🙏🏻🇺🇸🙏🏻